ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Carcinoma
Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Lung Cancer
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near San Antonio, TX, USA:

Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer

A Phase 1/1b dose finding study to determine the OBD(s) and RP2D(s) of BMF-219, a covalent menin inhibitor small molecule, in subjects with KRAS muta...

Enrolling
Stage III Non-small Cell Lung Cancer
Stage III Pancreatic Cancer
Drug: BMF-219

Phase 1

Biomea Fusion

San Antonio, Texas, United States and 22 other locations

and clinical activity of AB680 in combination with Zimberelimab (AB122), nab-paclitaxel and gemcitabine in participants with advanced pancreatic...

Enrolling
Advanced Pancreatic Cancer
Drug: Gemcitabine
Drug: Zimberelimab

Phase 1

Arcus Biosciences
Arcus Biosciences

San Antonio, Texas, United States of America and 17 other locations

A Phase 1/2 Open-label, Multi-center Study of the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and in Combination with...

Enrolling
Solid Tumor
Metastatic Cancer
Drug: Gemcitabine/nab-paclitaxel
Drug: LYT-200

Phase 1, Phase 2

PureTech Health

San Antonio, Texas, United States of America and 11 other locations

AGX101 is an antibody-drug conjugate (ADC) therapy for tumor-forming cancers. The purpose of this study is to learn about AGX101 ef...

Enrolling
Advanced Cancer
Pancreatic Adenocarcinoma
Drug: AGX101

Phase 1

Angiex, Inc.

San Antonio, Texas, United States and 1 other location

is to evaluate the safety and tolerability of RMC-9805 as monotherapy and in combination with RMC-6236 in adults with KRAS G12D-mutant solid tumors...

Enrolling
Non-small Cell Lung Cancer (NSCLC)
Colorectal Cancer (CRC)
Drug: RMC-6236
Drug: RMC-9805

Phase 1

Revolution Medicines
Revolution Medicines

San Antonio, Texas, United States and 16 other locations

Evaluate the safety and tolerability of RMC-6236 in adults with specific RAS mutant advanced solid tumors....

Enrolling
Non-small Cell Lung Cancer (NSCLC)
Colorectal Cancer (CRC)
Drug: RMC-6236

Phase 1

Revolution Medicines
Revolution Medicines

San Antonio, Texas, United States and 14 other locations

The study is a first-in-human (FIH), open-label, multi-center phase 1/2 study of TSN1611 in subjects with KRAS G12D mutant advanced solid tumors...

Enrolling
Malignant Neoplasm
Drug: TSN1611

Phase 1, Phase 2

Tyligand Bioscience

San Antonio, Texas, United States and 2 other locations

This is a Phase 1/2, first-in-human, open-label, dose escalation and dose-expansion study of E-602, administered alone and in combination with cemipl...

Active, not recruiting
Breast Cancer
Colon Cancer
Biological: E-602
Biological: Cemiplimab

Phase 1, Phase 2

Palleon Pharmaceuticals

San Antonio, Texas, United States and 12 other locations

dose-escalation, safety, pharmacokinetics (PK), and biomarker study of CBX-12 in subjects with advanced or metastatic refractory solid tumors...

Active, not recruiting
Esophagus Cancer
Breast Cancer
Drug: CBX-12

Phase 1, Phase 2

Cybrexa Therapeutics

San Antonio, Texas, United States and 3 other locations

administered orally as monotherapy in patients with advanced solid tumors with gene alterations in the RAS- MAPK pathway for whom there are ...

Enrolling
Solid Tumor, Adult
Pancreatic Cancer
Drug: IK-595

Phase 1

Ikena Oncology

San Antonio, Texas, United States and 4 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems